Lifeboat Foundation

Pohoiki Beach appears to be step two of Intel’s process-architecture-optimization development model. Step three, a larger integration of Loihi chips to be called Pohoiki Springs, is scheduled to debut later this year. Neuromorphic design is still in a research phase, but this and similar projects from competitors such as IBM and Samsung should break ground for eventual commoditization and commercial use.

The new Pohoiki Beach builds on the 2017 success of Intel’s Loihi NPU.

Using a new technique, scientists have performed the world’s smallest magnetic resonance imaging to capture the magnetic fields of single atoms. It’s an incredible breakthrough that could improve quantum research, as well as our understanding of the Universe on subatomic scales.

“I am very excited about these results,” said physicist Andreas Heinrich of the Institute for Basic Sciences in Seoul. “It is certainly a milestone in our field and has very promising implications for future research.”

You’re probably most familiar with magnetic resonance imaging, or MRI, as a method used to image internal body structures in medicine. An MRI machine uses highly powerful magnets to induce a strong magnetic field around the body, forcing the spin of the protons in the nuclei of your body’s hydrogen atoms to align with the magnetic field, all without producing side-effects.

Scientists believe even moderate amounts of exercise can slow cognitive decline in people at risk of developing Alzheimer’s disease.

A study published in the journal JAMA Neurology found a total of around 8,900 steps per day appeared to slow rates of cognitive decline and brain volume loss in people who were at high risk. The individuals were considered at risk because of the levels of amyloid beta—a protein thought to play a role in Alzheimer’s— in their brain.

Dr. Jasmeer Chhatwal, Assistant Professor at Harvard Medical School and co-author of the research, told Newsweek: “These results suggest that very achievable levels of physical activity may be protective in those at high risk of cognitive decline and that this effect can be augmented further by lowering vascular risk.” Vascular risk factors include high blood pressure, obesity, smoking, diabetes, he explained.

You OWN your DNA data Let’s keep it that way.

EDNA Members monetize their genetic data by selling access to their data direct to researchers. With an average selling price of $350.00 and an average expectancy of up to 200 deals, this can translate to as much as $70,000.00 per person. Intended use and licensing of this data is controlled by smart contract and may include posted bonds provided by researchers to insure confidentiality and security of the data. Don’t give away this highly-valuable property. Claim it for yourself. Opt-In only when YOU decide. It’s your property and you should be in control.

Panorama 360, Moon, Apollo 11 — vol. 2 Apollo 50th anniversary Apollo 11.

My mission is to drastically improve your life by helping you break bad habits, build and keep new healthy habits to make you the best version of yourself. I read the books and do all the research and share my findings with you!

This video is an interview of Dr. Aubrey de Grey @ SENS on July 17, 2019. My wife, Lauren Nally, was our camerawoman.

Continue reading “Brent Nally interviews Dr. Aubrey de Grey @ SENS on July 17, 2019” »

‘Ruthlessly systematic’ research achieves qubit communication 200 times faster than ever before.

After a thunderous launch on a Saturn V rocket, a three day journey through the unforgiving environment of space and a daring descent in the Lunar Module, you’re here: standing on the Moon. Look around and take in the sights of the surface, just as Apollo 17 astronauts Eugene Cernan and Harrison Schmitt saw it almost 5 decades ago. #Apollo50th

https://go.nasa.gov/2YWTVI7

Two important developers of the celebrated Crispr gene-editing technology said they will make it easier for researchers to license their intellectual property, a move aimed at hastening innovation in the burgeoning field.

MilliporeSigma, the life-sciences tools division of German pharmaceutical giant Merck KGaA, and the Broad Institute of MIT and Harvard said researchers will be able to get nonexclusive rights to patents held by both organizations for research purposes with a single license.

Companies will have to pay a licensing fee. Nonprofit and academic institutions will be permitted to license the patents for free, the organizations said in a news release on Thursday.